Microbiology & Immunology - Research Publications

Permanent URI for this collection

Search Results

Now showing 1 - 5 of 5
  • Item
    Thumbnail Image
    The immunogenicity of a viral cytotoxic T cell epitope is controlled by its MHC-bound conformation
    Tynan, FE ; Elhassen, D ; Purcell, AW ; Burrows, JM ; Borg, NA ; Miles, JJ ; Williamson, NA ; Green, KJ ; Tellam, J ; Kjer-Nielsen, L ; McCluskey, J ; Rossjohn, J ; Burrows, SR (ROCKEFELLER UNIV PRESS, 2005-11-07)
    Thousands of potentially antigenic peptides are encoded by an infecting pathogen; however, only a small proportion induce measurable CD8(+) T cell responses. To investigate the factors that control peptide immunogenicity, we have examined the cytotoxic T lymphocyte (CTL) response to a previously undefined epitope ((77)APQPAPENAY(86)) from the BZLF1 protein of Epstein-Barr virus (EBV). This peptide binds well to two human histocompatibility leukocyte antigen (HLA) allotypes, HLA-B*3501 and HLA-B*3508, which differ by a single amino acid at position 156 ((156)Leucine vs. (156)Arginine, respectively). Surprisingly, only individuals expressing HLA-B*3508 show evidence of a CTL response to the (77)APQPAPENAY(86) epitope even though EBV-infected cells expressing HLA-B*3501 process and present similar amounts of peptide for CTL recognition, suggesting that factors other than peptide presentation levels are influencing immunogenicity. Functional and structural analysis revealed marked conformational differences in the peptide, when bound to each HLA-B35 allotype, that are dictated by the polymorphic HLA residue 156 and that directly affected T cell receptor recognition. These data indicate that the immunogenicity of an antigenic peptide is influenced not only by how well the peptide binds to major histocompatibility complex (MHC) molecules but also by its bound conformation. It also illustrates a novel mechanism through which MHC polymorphism can further diversify the immune response to infecting pathogens.
  • Item
    Thumbnail Image
    T cell receptor recognition of a 'super-bulged' major histocompatibility complex class I-bound peptide
    Tynan, FE ; Burrows, SR ; Buckle, AM ; Clements, CS ; Borg, NA ; Miles, JJ ; Beddoe, T ; Whisstock, JC ; Wilce, MC ; Silins, SL ; Burrows, JM ; Kjer-Nielsen, L ; Kostenko, L ; Purcell, AW ; McCluskey, J ; Rossjohn, J (NATURE PUBLISHING GROUP, 2005-11)
    Unusually long major histocompatibility complex (MHC) class I-restricted epitopes are important in immunity, but their 'bulged' conformation represents a potential obstacle to alphabeta T cell receptor (TCR)-MHC class I docking. To elucidate how such recognition is achieved while still preserving MHC restriction, we have determined here the structure of a TCR in complex with HLA-B(*)3508 presenting a peptide 13 amino acids in length. This complex was atypical of TCR-peptide-MHC class I interactions, being dominated at the interface by peptide-mediated interactions. The TCR assumed two distinct orientations, swiveling on top of the centrally bulged, rigid peptide such that only limited contacts were made with MHC class I. Although the TCR-peptide recognition resembled an antibody-antigen interaction, the TCR-MHC class I contacts defined a minimal 'generic footprint' of MHC-restriction. Thus our findings simultaneously demonstrate the considerable adaptability of the TCR and the 'shape' of MHC restriction.
  • Item
    Thumbnail Image
    The CDR3 regions of an immunodominant T cell receptor dictate the 'energetic landscape' of peptide-MHC recognition
    Borg, NA ; Ely, LK ; Beddoe, T ; Macdonald, WA ; Reid, HH ; Clements, CS ; Purcell, AW ; Kjer-Nielsen, L ; Miles, JJ ; Burrows, SR ; McCluskey, J ; Rossjohn, J (NATURE PUBLISHING GROUP, 2005-02)
    The energetic bases of T cell recognition are unclear. Here, we studied the 'energetic landscape' of peptide-major histocompatibility complex (pMHC) recognition by an immunodominant alphabeta T cell receptor (TCR). We quantified and evaluated the effect of natural and systematic substitutions in the complementarity-determining region (CDR) loops on ligand binding in the context of the structural detail of each component of the immunodominant TCR-pMHC complex. The CDR1 and CDR2 loops contributed minimal energy through direct recognition of the antigen and instead had a chief function in stabilizing the ligated CDR3 loops. The underlying energetic basis for recognition lay in the CDR3 loops. Therefore the energetic burden of the CDR loops in the TCR-pMHC interaction is variable among TCRs, reflecting the inherent adaptability of the TCR in ligating different ligands.
  • Item
    Thumbnail Image
    A naturally selected dimorphism within the HLA-B44 supertype alters class I structure, peptide repertoire, and T cell recognition
    Macdonald, WA ; Purcell, AW ; Misfud, NA ; Ely, LK ; Williams, DS ; Chang, LN ; Gorman, J ; Clements, CS ; Kjer-Nielsen, L ; Koelle, DM ; Burrows, SR ; Tait, BD ; Holdsworth, R ; Brooks, AG ; Lovrecz, GO ; Lu, L ; Rossjohn, J ; McCluskey, J (ROCKEFELLER UNIV PRESS, 2003-09-01)
    HLA-B*4402 and B*4403 are naturally occurring MHC class I alleles that are both found at a high frequency in all human populations, and yet they only differ by one residue on the alpha2 helix (B*4402 Asp156-->B*4403 Leu156). CTLs discriminate between HLA-B*4402 and B*4403, and these allotypes stimulate strong mutual allogeneic responses reflecting their known barrier to hemopoeitic stem cell transplantation. Although HLA-B*4402 and B*4403 share >95% of their peptide repertoire, B*4403 presents more unique peptides than B*4402, consistent with the stronger T cell alloreactivity observed toward B*4403 compared with B*4402. Crystal structures of B*4402 and B*4403 show how the polymorphism at position 156 is completely buried and yet alters both the peptide and the heavy chain conformation, relaxing ligand selection by B*4403 compared with B*4402. Thus, the polymorphism between HLA-B*4402 and B*4403 modifies both peptide repertoire and T cell recognition, and is reflected in the paradoxically powerful alloreactivity that occurs across this "minimal" mismatch. The findings suggest that these closely related class I genes are maintained in diverse human populations through their differential impact on the selection of peptide ligands and the T cell repertoire.
  • Item
    Thumbnail Image
    Natural HLA class 1 polymorphism controls the pathway of antigen presentation and susceptibility to viral evasion
    Zernich, D ; Purcell, AW ; Macdonald, WA ; Kjer-Nielsen, L ; Ely, LK ; Laham, N ; Crockford, T ; Mifsud, NA ; Bharadwaj, M ; Chang, L ; Tait, BD ; Holdsworth, R ; Brooks, AG ; Bottomley, SP ; Beddoe, T ; Peh, CA ; Rossjohn, J ; McCluskey, J (ROCKEFELLER UNIV PRESS, 2004-07-05)
    HLA class I polymorphism creates diversity in epitope specificity and T cell repertoire. We show that HLA polymorphism also controls the choice of Ag presentation pathway. A single amino acid polymorphism that distinguishes HLA-B*4402 (Asp116) from B*4405 (Tyr116) permits B*4405 to constitutively acquire peptides without any detectable incorporation into the transporter associated with Ag presentation (TAP)-associated peptide loading complex even under conditions of extreme peptide starvation. This mode of peptide capture is less susceptible to viral interference than the conventional loading pathway used by HLA-B*4402 that involves assembly of class I molecules within the peptide loading complex. Thus, B*4402 and B*4405 are at opposite extremes of a natural spectrum in HLA class I dependence on the PLC for Ag presentation. These findings unveil a new layer of MHC polymorphism that affects the generic pathway of Ag loading, revealing an unsuspected evolutionary trade-off in selection for optimal HLA class I loading versus effective pathogen evasion.